The National Institute for Health and Care Excellence (NICE) has issued its Final Draft Guidance (FDG) recommending empagliflozin (Jardiance®) as an option for the treatment of eligible adults with chronic kidney disease (CKD). 1 NICE has applied a streamlined process to this assessment of empagliflozin – an .
Launch of innovative Cardio-diabetes clinic in Lincolnshire improves outcomes for patients with diabetes following a heart attack A cardio-diabetic outpatient service at Lincolnshire Heart Centre is helping reduce recurring heart attacks in people with diabetes by providing a holistic one-stop approach to patie.